Drugs & medicalType I

APO-AMITRIPTYLINE 10mg: NDMA Impurity

Contamination - Product safety

Read the official notice →
Date
2023-02-07
Country
Canada
Product
APO-AMITRIPTYLINE 10mg
Classification
Type I
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2023-02-09
  2. CA
    Drugs & medicalType II

    Heartsine Samaritan Pad 500P

    Labelling and packaging

    Health CanadaOfficial notice →
  3. 2023-02-08
  4. CA
    Drugs & medicalType I

    Tri-Staple™ 2.0 Black Intelligent Reload

    Performance

    Health CanadaOfficial notice →
  5. CA
    Drugs & medicalType II

    Anesthesia Set Flex, Latex Free, Us

    Performance

    Health CanadaOfficial notice →
  6. 2023-02-07
  7. CA
    Drugs & medicalType II

    Lina Librata, Endometrial Ablation Device

    Labelling and packaging

    Health CanadaOfficial notice →
  8. CA
    Drugs & medicalType II

    2D/3D Mammography Systems

    Performance

    Health CanadaOfficial notice →
  9. CA
    Drugs & medicalType II

    Aquacel Ag Foam Dressing, Adhesive

    Performance

    Health CanadaOfficial notice →
See all drugs & medical recalls →